SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-019048
Filing Date
2015-03-27
Accepted
2015-03-27 17:26:42
Documents
7
Period of Report
2015-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v405810_8-k.htm 8-K 21874
2 EXHIBIT 1.1 v405810_ex1-1.htm EX-1.1 194399
3 EXHIBIT 5.1 v405810_ex5-1.htm EX-5.1 6795
4 EXHIBIT 99.1 v405810_ex99-1.htm EX-99.1 9415
5 EXHIBIT 99.2 v405810_ex99-2.htm EX-99.2 9520
6 GRAPHIC logo.jpg GRAPHIC 2466
7 GRAPHIC logo1.jpg GRAPHIC 4182
  Complete submission text file 0001144204-15-019048.txt   252553
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 15731954
SIC: 2836 Biological Products, (No Diagnostic Substances)